JIP
ABMD

Jaffetilchin Investment Partners’s Abiomed Inc ABMD Stock Holding History

Jaffetilchin Investment Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-470
Closed -$211K – 374
2018
Q3 		$211K Sell
470
-1,490
-76% -$587K 0.04% 283
2018
Q2 		$802K Buy
+1,960
New +$710K 0.18% 106
2016
Q4 		– Sell
-2,419
Closed -$311K – 310
2016
Q3 		$311K Buy
+2,419
New +$290K 0.1% 163

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Jaffetilchin Investment Partners's ABMD Position: Q4 2018 in Review

Jaffetilchin Investment Partners sold out of Abiomed Inc (ABMD) in Q4 2018, closing a stake of 470 shares — an estimated $211K sold.

Jaffetilchin Investment Partners first reported a position in ABMD in Q3 2016 and held it in 3 quarters. The position peaked at $802K in Q2 2018. 529 funds tracked by Wall St. Rank hold ABMD as of Q4 2018.

  • Jaffetilchin Investment Partners reported no remaining Abiomed Inc position as of Q4 2018 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 470 Abiomed Inc shares in Q4 2018, an estimated $211K.
  • Jaffetilchin Investment Partners first reported a position in Abiomed Inc in Q3 2016 and held it in 3 quarters.
  • Jaffetilchin Investment Partners's Abiomed Inc position peaked at $802K in Q2 2018.
  • 529 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2018.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2018, filed 11 Feb 2019.